COVID-19: Using high-throughput flow cytometry to dissect clinical heterogeneity

Area of Science:

• Immunology
• Biotechnology

Background:

• COVID-19 presents complex immunological challenges.
• Understanding the immune response is crucial for patient management.

Purpose of the Study:

• To evaluate high-content flow cytometry for identifying COVID-19 immune signatures.
• To explore the impact of SARS-CoV-2 on cancer patients' immune systems.
• To develop biomarkers for COVID-19 severity.

Main Methods:

• Utilized high-throughput flow cytometry with lymphocyte and myelomonocyte panels.
• Integrated flow cytometry data with antibody titers, cytokine levels, and clinical annotations.
• Employed a novel T_DS assay to identify cycling T cells.

Main Results:

• Identified a consensus immune signature in COVID-19 patients.
• Revealed distinct immunological changes in cancer patients exposed to SARS-CoV-2.
• Detected abnormalities differentiating COVID-19 patients from healthy and non-COVID-19 respiratory infection groups.
• Discovered potential biomarkers for COVID-19 severity.

Conclusions:

• High-content flow cytometry is effective for rapid, meaningful biological data generation in COVID-19 research.
• This methodology offers accessible tools for clinical decision-making.
• Flow cytometry can identify subtle yet critical immune changes associated with COVID-19.